預填充生物藥物輸送系統市場 (-2028)

特種預填充注射器，包括筆和自動注射器，正在為藥物開發商和市場參與者創造新的機會。 這些設備提供了在直接面向消費者的銷售時代區分產品的能力。

本報告考察了全球可預填充生物藥物輸送系統市場，並提供了市場概況，包括按細分市場劃分的產品概況、監管趨勢以及進入該市場的公司概況。

內容

執行摘要

生物製劑的傳播

• 治療性單克隆抗體
• 治療需求的驅動因素
• 競爭格局
• 風險因素
• 用於生物製品的可預填充商業設備
• 手動注射自動注射器
• 自動注射自動注射器
• 一次性自動注射器

汽車注射器產品概述

• Molly
• Molly RNS
• Bertha
• Maggie
• Amber
• SafeLock
• VSDI +NIT
• SDI MIX +NIT
• Syrina Platform
• Syrina S
• Syrina AS
• AutoJect 2
• SelfDose
• Flexi-Q PFS
• OTS Autoinjector
• Consort Medical ASI
• Ypsomed VarioJect
• Rotaject Technology
• Viscala Autoinjector
• Flexi-Q HV
• Intevia

無線自動注射器

• BETACONNECT
• DataPen
• OneJet
• Alubena
• Flexi-Q eMU
• RebiSmart
• 特定於產品的預填充自動注射器
• Alsuma/Sumatriptan Autoinjector
• Sumatriptan
• Rebif/Rebidose
• Aimovig
• Enbrel Mini AutoTouch
• Pegasys Proclick
• Rasuvo
• Otrexup
• Evzio

設備設計因素

• 材料選擇問題
• 零件數量和設備成本
• 安全功能
• 進針深度
• 故障保護激活
• 劑量檢查/注射確認
• 凍乾藥物/重構
• 人體工程學/人體工程學

筆式註射器

• 標準化筆平台
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Ypsomed
• SHL Medical
• 定製筆設計
• 可重複使用的筆
• 雙腔筆

商業鋼筆產品

• 促性腺激素筆
• Humatropen/Humatropen 3
• Hematropen 產品概覽
• 去甲腎上腺素
• Neutropin AQ 筆
• Neutropin AQ Pen 概述
• Omnitrope
• Omnitrope Pen 產品概述
• one.click
• one.click 筆產品概述
• 副甲狀腺激素
• Forteo Pen
• Preotact/Preos
• Natpara

生殖激素

• 專業筆類產品
• Follistim/Puregon 筆
• Follistim Pen 產品概覽
• Gonal-f
• Gonal-f Rediject 筆產品概述
• 可穿戴設備
• 貼片泵
• 很多可穿戴設備
• 可穿戴產品分析
• Libertas
• 貼片泵
• SmartDose
• Neulasta OnPro Injector
• YpsoDose

電子半一次性

• E3D 貼片泵
• 一次性機械
• enFuse
• 俘虜設備
• sc2Wear Infuso
• 貼片泵
• 新興技術
• 無線數據

重點治療領域分析

• 過敏反應和對策
• 自身免疫性疾病
• 類風濕性關節炎
• 銀屑病
• 多發性硬化症
• 艾塞那□
• 佈道龍
• 普尼□
• 阿布魯□
• 緊急護理
• 肝炎
• 造血
• 荷爾蒙
• 骨質疏鬆症

市場因素

• 監管問題
• 設備品牌
• 患者依從性和可用性
• 醫療經濟學
• 公司簡介

“Prefillable Biological Drug Delivery Systems to 2028 ” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this growing segment of the drug delivery sector. The report has been designed and developed to provide pharmaceutical company decision makers, drug developers and formulators, drug device designers, and industry strategists with a detailed understanding of the expanding impact of biological drug self-care on pharmaceutical strategies and healthcare treatment protocols. Provider organization business managers, healthcare administrators and investors will also benefit from this publication.

Device Evolution and the Growth of Self-care Biologics

Specialty prefilled injection devices - a group that includes pen injectors and autoinjectors - are creating new opportunities for drug developers and marketers. These devices provide the ability to create product differentiation in the age of direct-to-consumer marketing.

Because biological drugs most often target chronic conditions, dosing strategies and treatment protocols must be developed for long-term use, often for self-administration by patients who may have limitations directly related to their condition. The shift in as-supplied packaging from single and multi-use vials to prefilled injection devices will accelerate over the next five years as drug developers move to empower an increasing number of chronically ill patients. The powerful physiological effects of antibodies, hormones and other biological drugs also increase the need for safety and compliance.

What You Will Learn:

• What are the market factors driving commercial activity in the biologicals drug delivery segment?

• What are the major factors driving as-supplied product development decisions within biological drug development organizations?

• How does the availability of patient support resources influence the prescribing decision for biological drugs?

• How important are drug developer-formulation technologist relationships in the biological drug packaging segment?

• What are the key influencers regarding as-supplied packaging in the biological self-administration market segment?

• What are the significant economic, technology, and regulatory factors affecting the selection criteria for self-administered biological drugs?

Table of Contents

Executive Summary

• Prefillable Biological Drug Delivery Systems
• The Market Opportunity
• Delivery Market Dynamics
• The Economics of Injectable Drugs
• What's Driving the Growth in Injectable Devices?
• Prefilled Syringes Proliferating
• The Trend toward Self-Administration
• Shifting Demographics
• Innovation in Disposable Device Designs

Proliferation of Biological Drugs

• Therapeutic Monoclonal Antibodies
• Therapeutic Demand Drivers
• Competitive Landscape
• Risk Factors
• Prefillable Commercial Devices for Biologicals
• Manual Injection Autoinjectors
• Automated Injection Autoinjectors
• Disposable Autoinjectors

Autoinjector Product Summaries

• Molly
• Molly RNS
• Bertha
• Maggie
• Amber
• SafeLock
• VSDI +NIT
• SDI MIX +NIT
• Syrina Platform
• Syrina S
• Syrina AS
• AutoJect 2
• SelfDose
• Flexi-Q PFS
• OTS Autoinjector
• Consort Medical ASI
• Ypsomed VarioJect
• Rotaject Technology
• Viscala Autoinjector
• Flexi-Q HV
• Intevia

Wirelessly Enabled Autoinjectors

• BETACONNECT
• DataPen
• OneJet
• Alubena
• Flexi-Q eMU
• RebiSmart
• Selected Product Specific Prefillable Autoinjectors
• Alsuma/Sumatriptan Autoinjector
• Sumatriptan
• Rebif/Rebidose
• Aimovig
• Enbrel Mini AutoTouch
• Pegasys Proclick
• Rasuvo
• Otrexup
• Evzio

Device Design Factors

• Material Selection Issues
• Part Counts and Device Cost
• Safety Features
• Needle Insertion Depth
• Failsafe Activation
• Dose Inspection/Injection Confirmation
• Lyophilized Drugs/Reconstitution
• Human Engineering/Ergonomics

Pen Injectors

• Standardized Pen Platforms
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Ypsomed
• SHL Medical
• Custom Pen Designs
• Reusable Pens
• Dual Chamber Pens

Commercial Pen Products

• Genotropin Pen
• Humatro-Pen/Humatro Pen 3
• Hematro-Pen Product Summary
• Norditropin
• Nutropin AQ Pen
• Nutropin AQ Pen Summary
• Omnitrope
• Omnitrope Pen Product Summary
• One.Click
• one.click Pen Product summary
• Parathyroid Hormones
• Forteo Pen
• Preotact/Preos
• Natpara

Reproductive Hormones

• Commercial Pen Products
• Follistim/Puregon Pen
• Follistim Pen Product Summary
• Gonal-f
• Gonal-f Rediject Pen Product Summary
• Wearable Devices
• Patch Pumps
• Large Volume Wearable Devices
• Wearables Product Analysis
• Libertas
• Patch Pump
• SmartDose
• Neulasta OnPro Injector
• YpsoDose

Electronic Semi-disposable

• E3D Patch Pump
• Mechanical Disposable
• enFuse
• Captive Devices
• sc2Wear Infusor
• PatchPump
• Emerging Technology
• Wireless Data

Key Therapeutic Sector Analysis

• Anaphylaxis/Countermeasures
• Autoimmune Diseases
• Rheumatoid Arthritis
• Psoriasis
• Multiple Sclerosis
• Exenatide
• Bydureon
• Pramlinitide
• Abliglutide
• Emergency Medicine
• Hepatitis
• Hematopoietics
• Hormones
• Osteoporosis

Market Factors

• Regulatory Issues
• Device Branding
• Patient Adherence and Ease of Use
• Healthcare Economics
• Company Profiles